BIODIVERSITY OF VIETNAM AND LAOS

描述：（申请人的描述） 人均国内生产总值约为1，140美元， 人类发展指数（HDI）在175个国家中排名第121位，越南是其中之一 世界上最不发达的国家。同样，老挝的GDP为 850美元，人类发展指数在175个国家中排名第136位， 发达国家。这两个国家都拥有丰富的热带生物多样性。 然而，这些丰富的生物多样性正受到威胁：森林砍伐率 越南估计为600平方公里/年，老挝为1，00平方公里/年。 显然，无论这两个国家的热带生物多样性如何， 作为一种资源，必须对其进行调查， 经济潜力。证明了这些森林可以提供新的 药品和国家一般收入将有助于加强 保护这些高度多样化的生态系统。鉴于长期以来- 联合国各组织之间存在的长期关系 首席研究员，在合作研究计划 伊利诺伊大学芝加哥分校药学 （PCRPS/LAC）和越南的两个研究机构，国家中心， 自然科学和技术部和Cuc Chongong国家公园， 一方面，在PCRPS/UIC和研究所之间， 老挝的药用植物，另一方面，提出了一项建议， 初步为期五年的合作研究。长期 研究的目标是：（1）对 这些国家的热带森林植物多样性和药用植物利用 (Cuc越南的阮松国家公园， 选择性的部落群体在老挝）;（2）发现新的生物学 来自两国植物的活性分子作为可能的候选者 用于治疗疟疾、病毒性疾病的药物开发 （包括艾滋病）及中枢神经系统相关疾病;及（三）提高 的生活的部落社区的成员研究，和 通过社区教育和生物质生产， 已经被确定为具有经济前景的植物 潜力，尤其是医疗潜力。一个工业合作伙伴，葛兰素 英国斯蒂夫尼奇的惠康研究与发展有限公司将加强 这个PCRPS/UIC为基础的国际合作生物多样性集团（ICBG）。

DESCRIPTION: (Applicant's Description) With a Gross Domestic Product (GDP) of about $1,140 per capita, and a Human Development Index (HDI) ranking of 121 out of 175, Vietnam is one of the least developed nations in the world. Similarly, Laos, with a GDP of $850 and a HDI ranking of 136 out of 175, is another of the least developed nations. Both countries possess a high tropical biodiversity. Yet these rich biodiversities are under threat: the rate of deforestation is estimated at 600 sq km/year for Vietnam, and 1,00 sq km/year for Laos. Clearly, whatever tropical biodiversity each of these two countries still has must be protected, and, as a resource, must be investigated for its economic potential. A demonstration that these forests could provide new medicines and general revenue for the country would help strengthen the cause of protecting these highly diverse ecosystems. In view of a long- standing relationship that exists between the organization of the Principal Investigator, the Program for Collaborative Research in the Pharmaceutical Sciences at the University of Illinois at Chicago (PCRPS/LAC), and two research institutions in Vietnam, the National Center for Natural Sciences and Technology and the Cuc Phuong National Park, on the one hand, and between the PCRPS/UIC and the Research Institute for Medicinal Plants in Laos, on the other, a proposal is made to carry out a collaborative study for an initial period of five years. The long-term objectives of the study are (1) to undertake a documented inventory of tropical forest plant diversity and medicinal plant use in these countries (Cuc Phuong National Park in Vietnam, and ethnobotanical surveys of selective tribal groups in Laos); (2) to discovered novel biologically active molecules from plants from both countries as possible candidates for drug development in the treatment of malaria, viral diseases (including AIDS) and CNS-related diseases; and (3) to improve the standard of living of the members of the tribal communities studied, and of the countries in general, through community education and biomass production of plants that have been identified as having promising economic potential, particularly medicinal potential. An industrial partner, Glaxo Wellcome Research and Development Limited, Stevenage, UK, will strengthen this PCRPS/UIC-based International Cooperative Biodiversity Group (ICBG).